Paul MacLean
Concepts (667)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 59 | 2026 | 3118 | 5.100 |
Why?
| | Weight Gain | 26 | 2023 | 561 | 4.370 |
Why?
| | Energy Metabolism | 33 | 2025 | 935 | 4.260 |
Why?
| | Weight Loss | 28 | 2026 | 859 | 4.110 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 242 | 2.340 |
Why?
| | Rats, Wistar | 19 | 2024 | 450 | 2.160 |
Why?
| | Energy Intake | 18 | 2025 | 512 | 2.070 |
Why?
| | Dietary Fats | 15 | 2026 | 308 | 1.960 |
Why?
| | Caloric Restriction | 9 | 2025 | 133 | 1.690 |
Why?
| | Ovariectomy | 11 | 2025 | 166 | 1.670 |
Why?
| | Body Weight | 16 | 2024 | 972 | 1.460 |
Why?
| | Lactation | 8 | 2020 | 193 | 1.410 |
Why?
| | Adipose Tissue | 15 | 2022 | 645 | 1.360 |
Why?
| | Appetite | 3 | 2025 | 80 | 1.290 |
Why?
| | Diet, High-Fat | 15 | 2023 | 266 | 1.290 |
Why?
| | Milk, Human | 6 | 2022 | 175 | 1.220 |
Why?
| | Body Composition | 12 | 2024 | 693 | 1.180 |
Why?
| | Ovary | 5 | 2024 | 234 | 1.120 |
Why?
| | Rats | 34 | 2024 | 5585 | 1.110 |
Why?
| | Adipocytes | 7 | 2025 | 223 | 1.090 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1791 | 1.050 |
Why?
| | Overweight | 7 | 2026 | 614 | 1.040 |
Why?
| | Animals | 87 | 2026 | 38097 | 1.030 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 47 | 1.000 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 79 | 1.000 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 143 | 0.920 |
Why?
| | Motor Activity | 3 | 2019 | 718 | 0.920 |
Why?
| | Lipid Metabolism | 9 | 2017 | 529 | 0.910 |
Why?
| | Appetite Regulation | 2 | 2017 | 31 | 0.840 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 560 | 0.800 |
Why?
| | Biomedical Research | 3 | 2023 | 719 | 0.770 |
Why?
| | Liver | 11 | 2024 | 1899 | 0.760 |
Why?
| | Cholesterol | 5 | 2019 | 408 | 0.750 |
Why?
| | Fasting | 7 | 2025 | 279 | 0.740 |
Why?
| | Milk | 6 | 2019 | 119 | 0.740 |
Why?
| | Leptin | 8 | 2025 | 248 | 0.730 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 317 | 0.730 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 56 | 0.730 |
Why?
| | Vasopressins | 3 | 2021 | 61 | 0.730 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 266 | 0.730 |
Why?
| | Awards and Prizes | 1 | 2023 | 71 | 0.720 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 18 | 0.720 |
Why?
| | Estrogens | 3 | 2018 | 367 | 0.720 |
Why?
| | Eating | 5 | 2022 | 387 | 0.720 |
Why?
| | Breast Feeding | 5 | 2022 | 447 | 0.710 |
Why?
| | Lipogenesis | 3 | 2019 | 62 | 0.710 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 128 | 0.690 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 62 | 0.690 |
Why?
| | Glycoproteins | 5 | 2005 | 354 | 0.670 |
Why?
| | Receptor, Insulin | 3 | 2015 | 93 | 0.660 |
Why?
| | Insulin | 19 | 2022 | 2516 | 0.640 |
Why?
| | Estradiol | 1 | 2024 | 515 | 0.630 |
Why?
| | Exercise | 11 | 2025 | 2205 | 0.610 |
Why?
| | Oxygen Consumption | 5 | 2019 | 719 | 0.610 |
Why?
| | Female | 69 | 2026 | 79035 | 0.610 |
Why?
| | Breast Neoplasms | 7 | 2026 | 2393 | 0.610 |
Why?
| | Weight Reduction Programs | 4 | 2026 | 140 | 0.610 |
Why?
| | Thermogenesis | 2 | 2019 | 45 | 0.610 |
Why?
| | Physical Exertion | 3 | 2011 | 205 | 0.600 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 212 | 0.600 |
Why?
| | Carrier Proteins | 6 | 2005 | 729 | 0.580 |
Why?
| | Cold Temperature | 2 | 2019 | 206 | 0.580 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 655 | 0.560 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 120 | 0.550 |
Why?
| | Sex Characteristics | 3 | 2021 | 789 | 0.540 |
Why?
| | Menopause | 2 | 2019 | 326 | 0.540 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 58 | 0.540 |
Why?
| | Calorimetry, Indirect | 6 | 2025 | 72 | 0.520 |
Why?
| | Diet | 10 | 2023 | 1278 | 0.520 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.510 |
Why?
| | Cortical Bone | 1 | 2017 | 15 | 0.510 |
Why?
| | Mice | 35 | 2026 | 18355 | 0.500 |
Why?
| | Insulin Resistance | 9 | 2025 | 1244 | 0.500 |
Why?
| | Adiposity | 5 | 2016 | 532 | 0.500 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.500 |
Why?
| | Diet, Reducing | 4 | 2021 | 91 | 0.490 |
Why?
| | Ibuprofen | 1 | 2017 | 87 | 0.490 |
Why?
| | Metformin | 2 | 2018 | 329 | 0.490 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 96 | 0.470 |
Why?
| | Placenta | 1 | 2023 | 787 | 0.470 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.470 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2601 | 0.460 |
Why?
| | Osteogenesis | 2 | 2017 | 204 | 0.460 |
Why?
| | Bone Density | 1 | 2019 | 487 | 0.460 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 404 | 0.450 |
Why?
| | Fructose | 5 | 2021 | 132 | 0.440 |
Why?
| | Oxytocin | 1 | 2015 | 51 | 0.440 |
Why?
| | Body Mass Index | 12 | 2026 | 2447 | 0.440 |
Why?
| | Male | 62 | 2026 | 73003 | 0.430 |
Why?
| | Therapies, Investigational | 1 | 2014 | 19 | 0.430 |
Why?
| | Mothers | 4 | 2018 | 765 | 0.430 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 101 | 0.420 |
Why?
| | Humans | 75 | 2026 | 145763 | 0.420 |
Why?
| | Feces | 7 | 2025 | 496 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 346 | 0.410 |
Why?
| | Transcription Factors | 13 | 2019 | 1736 | 0.400 |
Why?
| | Fatty Acids | 8 | 2022 | 457 | 0.400 |
Why?
| | Basal Metabolism | 3 | 2021 | 59 | 0.390 |
Why?
| | Fructokinases | 5 | 2021 | 42 | 0.380 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 56 | 0.380 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4568 | 0.380 |
Why?
| | Overnutrition | 1 | 2012 | 28 | 0.370 |
Why?
| | Fatty Liver | 5 | 2018 | 253 | 0.370 |
Why?
| | Pregnancy | 10 | 2023 | 7215 | 0.360 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 79 | 0.350 |
Why?
| | Blood Glucose | 10 | 2019 | 2344 | 0.350 |
Why?
| | Feeding Behavior | 5 | 2025 | 692 | 0.340 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1101 | 0.340 |
Why?
| | Recurrence | 4 | 2019 | 1139 | 0.340 |
Why?
| | Sheep | 4 | 2023 | 876 | 0.330 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 244 | 0.330 |
Why?
| | Estrous Cycle | 1 | 2010 | 22 | 0.320 |
Why?
| | Lipoproteins | 3 | 2000 | 166 | 0.310 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 32 | 0.310 |
Why?
| | Homeostasis | 7 | 2015 | 644 | 0.310 |
Why?
| | RNA, Messenger | 10 | 2019 | 2805 | 0.310 |
Why?
| | Gastrointestinal Microbiome | 4 | 2026 | 768 | 0.300 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 151 | 0.300 |
Why?
| | Glucose | 10 | 2023 | 1048 | 0.300 |
Why?
| | Vitamin D | 1 | 2013 | 404 | 0.300 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 24 | 0.290 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 148 | 0.280 |
Why?
| | Cattle | 6 | 2025 | 946 | 0.280 |
Why?
| | Huntington Disease | 2 | 2021 | 61 | 0.280 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 147 | 0.280 |
Why?
| | Mice, Inbred C57BL | 17 | 2026 | 5992 | 0.280 |
Why?
| | Time Factors | 11 | 2019 | 7133 | 0.280 |
Why?
| | Adult | 34 | 2026 | 40872 | 0.270 |
Why?
| | Behavior Therapy | 2 | 2021 | 296 | 0.270 |
Why?
| | Mice, Knockout | 13 | 2026 | 3130 | 0.270 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 35 | 0.260 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1247 | 0.260 |
Why?
| | Adiponectin | 5 | 2025 | 242 | 0.250 |
Why?
| | Triglycerides | 8 | 2019 | 520 | 0.250 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 68 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 574 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1652 | 0.240 |
Why?
| | Intestinal Absorption | 2 | 2026 | 103 | 0.240 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2219 | 0.240 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 301 | 0.240 |
Why?
| | Birds | 2 | 2025 | 86 | 0.240 |
Why?
| | Receptors, Lipoprotein | 1 | 2026 | 15 | 0.240 |
Why?
| | Dehydration | 2 | 2016 | 58 | 0.230 |
Why?
| | Campylobacter jejuni | 1 | 2025 | 16 | 0.230 |
Why?
| | Cattle Diseases | 1 | 2025 | 21 | 0.230 |
Why?
| | Campylobacter Infections | 1 | 2025 | 18 | 0.230 |
Why?
| | Transcriptome | 4 | 2024 | 1042 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 178 | 0.230 |
Why?
| | Lymphoma | 1 | 2007 | 241 | 0.230 |
Why?
| | Epithelium | 2 | 2019 | 311 | 0.230 |
Why?
| | Adenocarcinoma | 1 | 2012 | 926 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2602 | 0.220 |
Why?
| | Signal Transduction | 6 | 2022 | 5223 | 0.220 |
Why?
| | Fetal Development | 3 | 2023 | 298 | 0.220 |
Why?
| | Muscle Proteins | 4 | 2012 | 243 | 0.220 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 361 | 0.220 |
Why?
| | Leukemia | 1 | 2007 | 246 | 0.220 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 435 | 0.210 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1482 | 0.200 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.200 |
Why?
| | Escherichia coli O157 | 1 | 2023 | 14 | 0.200 |
Why?
| | Physical Fitness | 2 | 2016 | 207 | 0.200 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2026 | 231 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 267 | 0.200 |
Why?
| | Multiple Myeloma | 1 | 2007 | 309 | 0.200 |
Why?
| | Animals, Newborn | 3 | 2017 | 896 | 0.200 |
Why?
| | Middle Aged | 25 | 2026 | 36302 | 0.200 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 22 | 0.190 |
Why?
| | Resistance Training | 3 | 2017 | 186 | 0.190 |
Why?
| | Salmonella enterica | 1 | 2023 | 52 | 0.190 |
Why?
| | Arteriosclerosis | 1 | 2003 | 83 | 0.190 |
Why?
| | Financing, Organized | 1 | 2023 | 36 | 0.190 |
Why?
| | Animal Feed | 3 | 2019 | 49 | 0.190 |
Why?
| | Transcriptional Activation | 2 | 2002 | 372 | 0.190 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 442 | 0.190 |
Why?
| | Cell Proliferation | 3 | 2017 | 2514 | 0.190 |
Why?
| | Ghrelin | 3 | 2025 | 42 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2460 | 0.180 |
Why?
| | Parturition | 1 | 2023 | 69 | 0.180 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1068 | 0.180 |
Why?
| | Tamoxifen | 3 | 2021 | 193 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 148 | 0.180 |
Why?
| | Exercise Tolerance | 3 | 2016 | 283 | 0.180 |
Why?
| | Postmenopause | 4 | 2022 | 394 | 0.170 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1450 | 0.170 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 60 | 0.170 |
Why?
| | Mycoplasma ovipneumoniae | 1 | 2021 | 2 | 0.170 |
Why?
| | Malus | 1 | 2021 | 12 | 0.170 |
Why?
| | Lactoglobulins | 2 | 2018 | 6 | 0.170 |
Why?
| | Recombinases | 1 | 2021 | 10 | 0.170 |
Why?
| | Polyphenols | 1 | 2021 | 21 | 0.170 |
Why?
| | Cancer Survivors | 1 | 2026 | 338 | 0.160 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.160 |
Why?
| | Mentors | 1 | 2023 | 217 | 0.160 |
Why?
| | Thinness | 3 | 2021 | 100 | 0.160 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.160 |
Why?
| | Liver X Receptors | 2 | 2019 | 29 | 0.160 |
Why?
| | DNA Methylation | 2 | 2017 | 690 | 0.160 |
Why?
| | Child Development | 2 | 2018 | 483 | 0.160 |
Why?
| | Cinnamates | 1 | 2000 | 12 | 0.160 |
Why?
| | Disease Progression | 4 | 2018 | 2865 | 0.160 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2021 | 55 | 0.160 |
Why?
| | Shiga-Toxigenic Escherichia coli | 1 | 2020 | 10 | 0.160 |
Why?
| | Gene Expression Profiling | 3 | 2018 | 1777 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2001 | 115 | 0.160 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 146 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2020 | 18 | 0.160 |
Why?
| | Soil | 1 | 2021 | 147 | 0.160 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 196 | 0.160 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1454 | 0.150 |
Why?
| | Random Allocation | 2 | 2019 | 365 | 0.150 |
Why?
| | Starch | 1 | 2019 | 22 | 0.150 |
Why?
| | Nutritive Value | 1 | 2019 | 41 | 0.150 |
Why?
| | Escherichia coli Infections | 1 | 2020 | 125 | 0.150 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 456 | 0.150 |
Why?
| | Foodborne Diseases | 1 | 2020 | 60 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1166 | 0.150 |
Why?
| | Weaning | 1 | 2019 | 51 | 0.150 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 35 | 0.150 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2019 | 41 | 0.140 |
Why?
| | Analysis of Variance | 4 | 2016 | 1300 | 0.140 |
Why?
| | Metabolic Diseases | 2 | 2018 | 114 | 0.140 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 121 | 0.140 |
Why?
| | Ileitis | 1 | 2019 | 33 | 0.140 |
Why?
| | Anti-Infective Agents | 1 | 2021 | 232 | 0.140 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 55 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2525 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 199 | 0.140 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2191 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 45 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Milk Hypersensitivity | 1 | 2018 | 18 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 163 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 35 | 0.140 |
Why?
| | Aromatase | 1 | 2018 | 37 | 0.140 |
Why?
| | Dairying | 3 | 2025 | 12 | 0.140 |
Why?
| | Glycogen | 6 | 2010 | 55 | 0.130 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.130 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.130 |
Why?
| | Rest | 1 | 2018 | 126 | 0.130 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.130 |
Why?
| | Postpartum Period | 2 | 2020 | 373 | 0.130 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 593 | 0.130 |
Why?
| | Malnutrition | 1 | 2019 | 86 | 0.130 |
Why?
| | Cell Size | 1 | 2017 | 93 | 0.130 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.130 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.130 |
Why?
| | Urea | 1 | 2017 | 85 | 0.130 |
Why?
| | Sucrose | 2 | 2018 | 114 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 83 | 0.130 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 79 | 0.130 |
Why?
| | Gene Editing | 1 | 2018 | 89 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2020 | 292 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 735 | 0.130 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 13 | 0.120 |
Why?
| | Chromatography, Gas | 1 | 2016 | 30 | 0.120 |
Why?
| | Running | 1 | 2019 | 233 | 0.120 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 64 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.120 |
Why?
| | Neural Pathways | 2 | 2011 | 317 | 0.120 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 201 | 0.120 |
Why?
| | Glaucoma | 1 | 2020 | 251 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 306 | 0.120 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.120 |
Why?
| | Dyslipidemias | 1 | 2018 | 184 | 0.120 |
Why?
| | Dogs | 1 | 2018 | 478 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2017 | 149 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 56 | 0.120 |
Why?
| | Paratuberculosis | 1 | 2015 | 2 | 0.120 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2015 | 3 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 179 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 730 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 17 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 669 | 0.110 |
Why?
| | Hypothalamus | 1 | 2016 | 163 | 0.110 |
Why?
| | Obesity, Morbid | 1 | 2000 | 293 | 0.110 |
Why?
| | Jejunum | 1 | 2015 | 37 | 0.110 |
Why?
| | Down-Regulation | 3 | 2008 | 618 | 0.110 |
Why?
| | Fibroblasts | 2 | 2017 | 1027 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 910 | 0.110 |
Why?
| | Up-Regulation | 3 | 2015 | 848 | 0.110 |
Why?
| | Deer | 1 | 2015 | 43 | 0.110 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.110 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.110 |
Why?
| | Crohn Disease | 1 | 2019 | 260 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 386 | 0.110 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 360 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2022 | 638 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Genetic Engineering | 1 | 2015 | 88 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 868 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1049 | 0.110 |
Why?
| | Trophoblasts | 1 | 2017 | 218 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 74 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 473 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 86 | 0.100 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 523 | 0.100 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 273 | 0.100 |
Why?
| | Arecaceae | 1 | 2014 | 2 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.100 |
Why?
| | Fetus | 1 | 2019 | 804 | 0.100 |
Why?
| | Genes, Plant | 1 | 2014 | 46 | 0.100 |
Why?
| | Infant | 5 | 2023 | 10090 | 0.100 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 517 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1723 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 70 | 0.100 |
Why?
| | United States | 3 | 2023 | 16123 | 0.100 |
Why?
| | Animals, Wild | 2 | 2025 | 62 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 992 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 26 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 253 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 117 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2009 | 513 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 62 | 0.090 |
Why?
| | Genome | 1 | 2015 | 305 | 0.090 |
Why?
| | Lipoproteins, HDL | 2 | 2026 | 100 | 0.090 |
Why?
| | Integrases | 1 | 2013 | 122 | 0.090 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 8 | 0.090 |
Why?
| | Cell Separation | 1 | 2013 | 306 | 0.090 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 209 | 0.090 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 675 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 821 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2013 | 192 | 0.090 |
Why?
| | Alleles | 1 | 2015 | 896 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 135 | 0.090 |
Why?
| | Histones | 1 | 2017 | 666 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1134 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1139 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 35 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 171 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2013 | 310 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2399 | 0.080 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 65 | 0.080 |
Why?
| | Biomarkers | 6 | 2019 | 4302 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 190 | 0.080 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2191 | 0.080 |
Why?
| | Glycolysis | 1 | 2012 | 340 | 0.080 |
Why?
| | Phylogeny | 3 | 2021 | 917 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 387 | 0.080 |
Why?
| | Colon | 1 | 2013 | 309 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 588 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4556 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2018 | 6464 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 21 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 976 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 42 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 383 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 40 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 318 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 267 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 263 | 0.080 |
Why?
| | Intestine, Small | 2 | 2026 | 167 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 546 | 0.070 |
Why?
| | Hypertension | 1 | 2018 | 1276 | 0.070 |
Why?
| | Fats | 1 | 2009 | 13 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 199 | 0.070 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 201 | 0.070 |
Why?
| | Adolescent | 6 | 2025 | 22573 | 0.070 |
Why?
| | Health Behavior | 1 | 2014 | 791 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 207 | 0.070 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 168 | 0.070 |
Why?
| | Young Adult | 6 | 2025 | 14251 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 364 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 876 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 344 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 192 | 0.070 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1399 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 440 | 0.070 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 508 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 610 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1708 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 28 | 0.060 |
Why?
| | Hyperplasia | 1 | 2008 | 177 | 0.060 |
Why?
| | Antigens, CD34 | 1 | 2007 | 90 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 175 | 0.060 |
Why?
| | Risk Factors | 3 | 2018 | 10917 | 0.060 |
Why?
| | Animals, Genetically Modified | 2 | 2018 | 247 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2016 | 11793 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 105 | 0.060 |
Why?
| | Nuclear Transfer Techniques | 2 | 2017 | 5 | 0.060 |
Why?
| | Leukocyte Count | 1 | 2007 | 318 | 0.060 |
Why?
| | Patient Selection | 2 | 2009 | 739 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2823 | 0.060 |
Why?
| | Chylomicrons | 1 | 2026 | 18 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 82 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 630 | 0.060 |
Why?
| | Proof of Concept Study | 1 | 2026 | 89 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 69 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 191 | 0.060 |
Why?
| | Multilocus Sequence Typing | 1 | 2025 | 16 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 779 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 59 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 798 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 81 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 28 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 2050 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1764 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 39 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 6 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 44 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2019 | 3634 | 0.050 |
Why?
| | Disease Resistance | 2 | 2015 | 29 | 0.050 |
Why?
| | Population Dynamics | 1 | 2025 | 142 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1751 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2018 | 17325 | 0.050 |
Why?
| | Proteins | 2 | 2013 | 1023 | 0.050 |
Why?
| | Proteomics | 2 | 2022 | 1188 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2967 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 209 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1568 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1507 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 154 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 309 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 45 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 51 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 558 | 0.050 |
Why?
| | Manure | 1 | 2023 | 7 | 0.050 |
Why?
| | Pilot Projects | 2 | 2022 | 1897 | 0.050 |
Why?
| | Colony Count, Microbial | 1 | 2023 | 89 | 0.050 |
Why?
| | Food Microbiology | 1 | 2023 | 39 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 638 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 376 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 264 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 312 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 28 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 40 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 277 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 295 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 112 | 0.050 |
Why?
| | Sex Factors | 2 | 2019 | 2110 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 85 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 77 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 57 | 0.050 |
Why?
| | Aged | 5 | 2018 | 26215 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2123 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2026 | 1474 | 0.040 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 79 | 0.040 |
Why?
| | Rodentia | 1 | 2022 | 61 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.040 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 39 | 0.040 |
Why?
| | Dinoprostone | 1 | 2022 | 180 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 88 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 138 | 0.040 |
Why?
| | Clostridium | 1 | 2021 | 19 | 0.040 |
Why?
| | Bacillus | 1 | 2021 | 17 | 0.040 |
Why?
| | Mice, Obese | 1 | 2021 | 68 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 146 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1115 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.040 |
Why?
| | Neutrophils | 1 | 2007 | 1125 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2003 | 225 | 0.040 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 81 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 143 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 214 | 0.040 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 39 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 325 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 73 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 44 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 354 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 85 | 0.040 |
Why?
| | Farms | 1 | 2020 | 8 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1857 | 0.040 |
Why?
| | Molecular Typing | 1 | 2020 | 21 | 0.040 |
Why?
| | Metabolomics | 1 | 2026 | 733 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 386 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 70 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 264 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 132 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 741 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 337 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 105 | 0.040 |
Why?
| | Plasmids | 1 | 2021 | 373 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 108 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2181 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 277 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 119 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 8 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2026 | 883 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 44 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 251 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 55 | 0.040 |
Why?
| | Ileostomy | 1 | 2019 | 26 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 8346 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 51 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 114 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 219 | 0.040 |
Why?
| | Child | 2 | 2022 | 22739 | 0.030 |
Why?
| | Mathematical Concepts | 1 | 2018 | 35 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.030 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 117 | 0.030 |
Why?
| | Colectomy | 1 | 2019 | 106 | 0.030 |
Why?
| | Prospective Studies | 2 | 2023 | 8075 | 0.030 |
Why?
| | Area Under Curve | 1 | 2019 | 332 | 0.030 |
Why?
| | Japan | 1 | 2018 | 149 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 2000 | 0.030 |
Why?
| | Transfection | 1 | 2000 | 927 | 0.030 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.030 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5922 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 35 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 121 | 0.030 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 43 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2018 | 191 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2069 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 486 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 28 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 429 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 666 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 143 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 50 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 28 | 0.030 |
Why?
| | Breast | 1 | 2018 | 156 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 208 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.030 |
Why?
| | Meat | 1 | 2018 | 64 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 213 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 627 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 361 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 167 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 295 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 118 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 215 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2913 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 618 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2969 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 242 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 279 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 158 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1165 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 194 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 361 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 160 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 749 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 154 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 108 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 226 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 124 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 849 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 211 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 630 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 188 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2015 | 22 | 0.030 |
Why?
| | Biological Products | 1 | 2019 | 257 | 0.030 |
Why?
| | Endonucleases | 1 | 2015 | 34 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 450 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2015 | 50 | 0.030 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 35 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 44 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 989 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1359 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 362 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4151 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 2064 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 849 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 85 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1082 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1191 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 321 | 0.030 |
Why?
| | RNA, Plant | 1 | 2014 | 10 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2014 | 43 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 731 | 0.030 |
Why?
| | Genetic Loci | 1 | 2015 | 267 | 0.030 |
Why?
| | Gene Ontology | 1 | 2014 | 54 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 396 | 0.020 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2014 | 106 | 0.020 |
Why?
| | Perfusion | 1 | 1995 | 251 | 0.020 |
Why?
| | Lipids | 1 | 1998 | 707 | 0.020 |
Why?
| | Cell Respiration | 1 | 2013 | 105 | 0.020 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 29 | 0.020 |
Why?
| | Testosterone | 1 | 2017 | 416 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3416 | 0.020 |
Why?
| | Plant Proteins | 1 | 2014 | 111 | 0.020 |
Why?
| | Betaine | 1 | 2013 | 67 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 85 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 330 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 157 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 2019 | 603 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 509 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 154 | 0.020 |
Why?
| | Plant Leaves | 1 | 2014 | 131 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 693 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 144 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 143 | 0.020 |
Why?
| | Base Sequence | 1 | 2015 | 2171 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1782 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 751 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2874 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 778 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2883 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2933 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1478 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 318 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 44 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 507 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1925 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5428 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 90 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 16 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3551 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 480 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3170 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 513 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3752 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 396 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 686 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 611 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 227 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 998 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 29 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.010 |
Why?
| | Breeding | 1 | 2006 | 63 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3915 | 0.010 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 32 | 0.010 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 29 | 0.010 |
Why?
| | PPAR alpha | 1 | 2006 | 55 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 33 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 199 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 227 | 0.010 |
Why?
| | Introns | 1 | 2005 | 256 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 4090 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 217 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 60 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 9 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 48 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 50 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 129 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 26 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 142 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 217 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2883 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 762 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1973 | 0.010 |
Why?
| | RNA | 1 | 2003 | 912 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 867 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 10 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 312 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 331 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 90 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3346 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1184 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 514 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|